CY2326B1 - HIV protease inhibitors in pharmaceutical combinant for the treatment of AIDS. - Google Patents

HIV protease inhibitors in pharmaceutical combinant for the treatment of AIDS.

Info

Publication number
CY2326B1
CY2326B1 CY0300041A CY0300041A CY2326B1 CY 2326 B1 CY2326 B1 CY 2326B1 CY 0300041 A CY0300041 A CY 0300041A CY 0300041 A CY0300041 A CY 0300041A CY 2326 B1 CY2326 B1 CY 2326B1
Authority
CY
Cyprus
Prior art keywords
treatment
aids
protease inhibitors
hiv protease
compounds
Prior art date
Application number
CY0300041A
Other languages
English (en)
Inventor
Joseph P Vacca
James P Guare
Bruce D Dorsey
M Katharine Holloway
Randall W Hungate
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CY2326B1 publication Critical patent/CY2326B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CY0300041A 1993-03-31 2003-05-07 HIV protease inhibitors in pharmaceutical combinant for the treatment of AIDS. CY2326B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4072993A 1993-03-31 1993-03-31

Publications (1)

Publication Number Publication Date
CY2326B1 true CY2326B1 (en) 2003-11-14

Family

ID=21912617

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0300041A CY2326B1 (en) 1993-03-31 2003-05-07 HIV protease inhibitors in pharmaceutical combinant for the treatment of AIDS.

Country Status (35)

Country Link
EP (1) EP0617968B1 (no)
JP (1) JPH08508496A (no)
KR (1) KR100311551B1 (no)
CN (1) CN1090186C (no)
AT (1) ATE230610T1 (no)
AU (1) AU685772B2 (no)
BG (1) BG62083B1 (no)
BR (1) BR9406503A (no)
CA (1) CA2120192A1 (no)
CY (1) CY2326B1 (no)
CZ (1) CZ286412B6 (no)
DE (1) DE69431972T2 (no)
DK (1) DK0617968T3 (no)
DZ (1) DZ1766A1 (no)
ES (1) ES2188604T3 (no)
FI (1) FI954580A (no)
HK (1) HK1009248A1 (no)
HR (1) HRP940209B1 (no)
HU (1) HUT74006A (no)
IL (1) IL109166A (no)
LV (1) LV13141B (no)
NO (1) NO953876L (no)
NZ (1) NZ265164A (no)
PL (1) PL310895A1 (no)
PT (1) PT617968E (no)
RO (1) RO118000B1 (no)
RU (1) RU2139052C1 (no)
SA (1) SA94140745B1 (no)
SG (1) SG64366A1 (no)
SI (1) SI9420017B (no)
SK (1) SK279471B6 (no)
TW (1) TW307684B (no)
WO (1) WO1994022480A1 (no)
YU (1) YU49275B (no)
ZA (1) ZA942255B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69430385T2 (de) * 1993-12-15 2002-11-07 Merck & Co., Inc. Hiv-proteaseinhibitoren
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US5476874A (en) * 1994-06-22 1995-12-19 Merck & Co., Inc. New HIV protease inhibitors
JPH10507917A (ja) * 1994-10-25 1998-08-04 メルク エンド カンパニー インコーポレーテッド Ｈｉｖプロテアーゼ阻害剤の微生物合成
US6689761B1 (en) 1995-02-01 2004-02-10 Merck & Co., Inc. Combination therapy for HIV infection
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
HU9701081D0 (en) * 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
EP1095022A1 (en) 1998-07-08 2001-05-02 G.D. Searle & Co. Retroviral protease inhibitors
AU6508899A (en) * 1998-10-13 2000-05-01 Du Pont Pharmaceuticals Company Selective eradication of virally-infected cells by combined use of a cytotoxic agent and an antiviral agent
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
KR20070083484A (ko) 2004-07-14 2007-08-24 피티씨 테라퓨틱스, 인크. Ｃ형 간염 치료 방법
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
NZ553329A (en) 2004-07-22 2010-09-30 Ptc Therapeutics Inc Thienopyridines for treating hepatitis C
RU2520967C1 (ru) * 2013-02-08 2014-06-27 Федеральное государственное бюджетное учреждение науки Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) СИММЕТРИЧНЫЕ ДИИМИНЫ НА ОСНОВЕ КАМФОРЫ - ИНГИБИТОРЫ РЕПРОДУКЦИИ ВИРУСА ГРИППА (ШТАММ A/California/07/09 (H1N1)pdm09)
CN109528747A (zh) * 2018-12-13 2019-03-29 中国人民解放军总医院 扎西他滨在制备抗菌消炎药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0641306A1 (en) * 1991-06-04 1995-03-08 Smithkline Beecham Corporation Carbocyclic and heterocyclic hiv protease inhibitors

Also Published As

Publication number Publication date
NO953876D0 (no) 1995-09-29
FI954580A0 (fi) 1995-09-27
PT617968E (pt) 2003-03-31
DE69431972T2 (de) 2003-08-28
BR9406503A (pt) 1996-01-02
HRP940209B1 (en) 2004-04-30
HRP940209A2 (en) 1998-02-28
HK1009248A1 (en) 1999-05-28
YU15994A (sh) 1999-06-15
HU9502860D0 (en) 1995-11-28
IL109166A (en) 1999-08-17
SK279471B6 (sk) 1998-11-04
CZ286412B6 (en) 2000-04-12
WO1994022480A1 (en) 1994-10-13
DK0617968T3 (da) 2003-02-24
DZ1766A1 (fr) 2002-02-17
SK122595A3 (en) 1997-03-05
SI9420017B (sl) 2003-12-31
BG100016A (en) 1996-04-30
BG62083B1 (bg) 1999-02-26
CN1090186C (zh) 2002-09-04
AU5921394A (en) 1994-10-06
NO953876L (no) 1995-11-30
ES2188604T3 (es) 2003-07-01
FI954580A (fi) 1995-09-27
CN1120316A (zh) 1996-04-10
SA94140745B1 (ar) 2006-07-11
RU2139052C1 (ru) 1999-10-10
PL310895A1 (en) 1996-01-08
SG64366A1 (en) 1999-04-27
SI9420017A (en) 1996-10-31
LV13141B (en) 2004-08-20
CZ252895A3 (en) 1996-07-17
HUT74006A (en) 1996-10-28
ZA942255B (en) 1994-11-01
DE69431972D1 (de) 2003-02-13
NZ265164A (en) 1997-09-22
CA2120192A1 (en) 1994-10-01
YU49275B (sh) 2005-03-15
EP0617968A1 (en) 1994-10-05
TW307684B (no) 1997-06-11
EP0617968B1 (en) 2003-01-08
RO118000B1 (ro) 2002-12-30
JPH08508496A (ja) 1996-09-10
IL109166A0 (en) 1994-06-24
KR960701661A (ko) 1996-03-28
KR100311551B1 (ko) 2001-12-28
AU685772B2 (en) 1998-01-29
ATE230610T1 (de) 2003-01-15

Similar Documents

Publication Publication Date Title
CY2326B1 (en) HIV protease inhibitors in pharmaceutical combinant for the treatment of AIDS.
AU2725392A (en) Hiv protease inhibitors
IN172553B (no)
EP0766674A4 (en) NOVEL HIV PROTEASE INHIBITORS
PL314984A1 (en) Hiv protease inhibitors
WO2002096359A3 (en) Piperazine pentanamide hiv protease inhibitors